Siglecs--the major subfamily of I-type lectins
- PMID: 16014749
- DOI: 10.1093/glycob/cwj008
Siglecs--the major subfamily of I-type lectins
Abstract
Animal glycan-recognizing proteins can be broadly classified into two groups-lectins (which typically contain an evolutionarily conserved carbohydrate-recognition domain [CRD]) and sulfated glycosaminoglycan (SGAG)-binding proteins (which appear to have evolved by convergent evolution). Proteins other than antibodies and T-cell receptors that mediate glycan recognition via immunoglobulin (Ig)-like domains are called "I-type lectins." The major homologous subfamily of I-type lectins with sialic acid (Sia)-binding properties and characteristic amino-terminal structural features are called the "Siglecs" (Sia-recognizing Ig-superfamily lectins). The Siglecs can be divided into two groups: an evolutionarily conserved subgroup (Siglecs-1, -2, and -4) and a CD33/Siglec-3-related subgroup (Siglecs-3 and -5-13 in primates), which appear to be rapidly evolving. This article provides an overview of historical and current information about the Siglecs.
Similar articles
-
Discovery of Siglec-14, a novel sialic acid receptor undergoing concerted evolution with Siglec-5 in primates.FASEB J. 2006 Oct;20(12):1964-73. doi: 10.1096/fj.06-5800com. FASEB J. 2006. PMID: 17012248
-
Siglecs: A journey through the evolution of sialic acid-binding immunoglobulin-type lectins.Dev Comp Immunol. 2018 Sep;86:219-231. doi: 10.1016/j.dci.2018.05.008. Epub 2018 May 8. Dev Comp Immunol. 2018. PMID: 29751010 Review.
-
CD33-related sialic-acid-binding immunoglobulin-like lectins in health and disease.Carbohydr Res. 2008 Aug 11;343(12):2050-6. doi: 10.1016/j.carres.2008.01.009. Epub 2008 Jan 17. Carbohydr Res. 2008. PMID: 18279844 Review.
-
A uniquely human consequence of domain-specific functional adaptation in a sialic acid-binding receptor.Glycobiology. 2004 Apr;14(4):339-46. doi: 10.1093/glycob/cwh039. Epub 2003 Dec 23. Glycobiology. 2004. PMID: 14693915
-
Siglecs: sialic-acid-binding immunoglobulin-like lectins in cell-cell interactions and signalling.Curr Opin Struct Biol. 2002 Oct;12(5):609-15. doi: 10.1016/s0959-440x(02)00375-5. Curr Opin Struct Biol. 2002. PMID: 12464312 Review.
Cited by
-
Antibody-based therapy of acute myeloid leukemia with gemtuzumab ozogamicin.Front Biosci (Landmark Ed). 2013 Jun 1;18(4):1311-34. doi: 10.2741/4181. Front Biosci (Landmark Ed). 2013. PMID: 23747885 Free PMC article. Review.
-
Multiple Genomic Events Altering Hominin SIGLEC Biology and Innate Immunity Predated the Common Ancestor of Humans and Archaic Hominins.Genome Biol Evol. 2020 Jul 1;12(7):1040-1050. doi: 10.1093/gbe/evaa125. Genome Biol Evol. 2020. PMID: 32556248 Free PMC article.
-
Evolution of siglec-11 and siglec-16 genes in hominins.Mol Biol Evol. 2012 Aug;29(8):2073-86. doi: 10.1093/molbev/mss077. Epub 2012 Mar 1. Mol Biol Evol. 2012. PMID: 22383531 Free PMC article.
-
Coronaviruses: Is Sialic Acid a Gate to the Eye of Cytokine Storm? From the Entry to the Effects.Cells. 2020 Aug 25;9(9):1963. doi: 10.3390/cells9091963. Cells. 2020. PMID: 32854433 Free PMC article.
-
First Evidence for a Role of Siglec-8 in Breast Cancer.Int J Mol Sci. 2021 Feb 18;22(4):2000. doi: 10.3390/ijms22042000. Int J Mol Sci. 2021. PMID: 33670444 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Molecular Biology Databases